Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
NEW YORK--(BUSINESS WIRE)--Ophthotech has acquired Inception 4, Inc., a company backed by Versant Ventures, expanding its pipeline in age-related retinal indications